Journal of Generic Medicine – Editorial December 2021

Abstract

Inspections by the FDA of Indian plants restarted around September 2021 after the pandemic shutdown with representatives from both the Indian and USA FDA offices in attendance. For generic drug facilities registered with the USA FDA at the end of 2021, India continues to have the largest number of Active Pharmaceutical Ingredient (API) manufacturing facilities (183). After the lowering of generic medicine prices in the first half of 2021, USA medicines prices seem to have stabilised in the last quarter. [Extracted from the article] Copyright of Journal of Generic Medicines is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)